Anebulo Pharmaceuticals, Inc. Business Finance Contracts & Agreements
9 Contracts & Agreements
- Investor Rights Agreements (1 contract)
- Loan Agreements (1)
- Purchase Agreements (1)
- Stock Agreements (2)
- Underwriting Agreements (1)
- Warrant Agreements (3)
- Loan and Security Agreement dated November 13, 2023, among the Company, 22NW LP as administrative agent, collateral agent and as a lender, and JFL Capital Management LLC (Filed With SEC on November 14, 2023)
- Form of Common Stock Purchase Warrant, issued September 28, 2022 (Filed With SEC on September 29, 2022)
- Securities Purchase Agreement, dated September 25, 2022, by and between the Company and the purchasers named therein (Filed With SEC on September 29, 2022)
- Form of Underwriting Agreement (Filed With SEC on April 26, 2021)
- Investors Rights Agreement, dated June 18, 2020, between Anebulo Pharmaceuticals, Inc. and 22NW, LP (Filed With SEC on April 1, 2021)
- Series A Preferred Stock Purchase Agreement, dated June 18, 2020, between Anebulo Pharmaceuticals, Inc. and 22NW, LP (Filed With SEC on April 1, 2021)
- Warrant to Purchase Shares of Preferred Stock, dated as of March 8, 2021, between Anebulo Pharmaceuticals, Inc. and 22NW, LP (Filed With SEC on April 1, 2021)
- Warrant to Purchase Shares of Preferred Stock, dated as of March 8, 2021, between Anebulo Pharmaceuticals, Inc. and Aron English (Filed With SEC on April 1, 2021)
- Specimen Stock Certificate for Common Stock (Filed With SEC on April 1, 2021)